News - NeuVax, PTC Therapeutics

Filter

Current filters:

NeuVaxPTC Therapeutics

Popular Filters

Galena Biopharma links with and Dr Reddy's for NeuVax in India

14-01-2014

USA-based Galena Biopharma and India’s second-largest drugmaker Dr Reddy's Laboratories have entered…

Asia-PacificDr Reddy's LaboratoriesGalena BioPharmaIndiaLicensingNeuVaxOncologyPharmaceutical

Galena Biopharma leaps on deal with Teva for NeuVax in Israel

05-12-2012

Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading…

BiotechnologyGalena BioPharmaLicensingnelipepimut-SNeuVaxOncologyRest of the WorldTeva Pharmaceutical IndustriesVaccines

Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena

30-11-2011

Swiss drug major Roche (ROG: SIX) has signed a licensing agreement with privately-held US firm PTC Therapeutics…

Galena BioPharmaHerceptinLicensingNeuVaxOncologyPharmaceuticalPTC TherapeuticsRare diseasesResearchRoche

PTC Therapeutics and Genzyme restructuring ataluren collaboration

04-09-2011

Privately-held PTC Therapeutics and fellow USA-based Genzyme, now part of French drug major Sanofi (Euronext:…

atalurenGenzymeLicensingPharmaceuticalPTC TherapeuticsRare diseasesSanofi

AstraZeneca gets UK NICE backing for Brilique; collaborates with PTC for oncology and other potential drugs

30-06-2011

There was good news this morning for Anglo-Swedish drug major AstraZeneca (LSE: AZN), when the UK’s…

AstraZenecaBrilintaBriliqueCardio-vascularEuropeOncologyPharmaceuticalPTC TherapeuticsRegulationResearch

Back to top